Skip to main content
Equibles

OKYO · OKYO Pharma Ltd

Track OKYO — free

Use OKYO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OKYO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.40 -0.03 (-2.10%) At close · Sep 11
Rebalance outlook locked
Market Cap
$73.47M
Shares
52.48M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.40 Open$1.46 Day$1.39–1.47 52W close$1.37–3.11 Avg vol 30d72K Short int54K · 0.1% float · 1.0d Short vol32% DataMay 2022–Sep 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-35.5%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Very Bullish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −19%
below
Price vs 50-day avg −10%
below
RSI (14) 39
neutral
MACD trend Negative
52-week position 2%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −7%
trailing
6-month return −11%
trailing
YTD return −32%
this year
Relative strength −29%
vs S&P · 6-mo
Sentiment
smart money
Very Bullish
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+58% holders QoQ · +8 funds added
Insider flow Accumulating
Net +$136.0K over 90 days · 0% sells
Short interest Falling
0.10% of float · ▼ -35.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
19 holders — near 3-yr high, broad support
Squeeze score 20
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 77%
annualized · 1-yr
Max drawdown −56%
past year
ATR 7.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−19% Bearish
Price vs 50-day avg
−10% Bearish
RSI (14)
39 Neutral
MACD trend
Negative Bearish
52-week position
2% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+58% holders QoQ · +8 funds added
Insider flow Accumulating
Net +$136.0K over 90 days · 0% sells
Short interest Falling
0.10% of float · ▼ -35.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
19 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $1 · 2% Range high $3
vs 200-day avg -19% vs 50-day avg -10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OKYO
OKYO Pharma Ltd
this stock
$73.47M -32.4% — — 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.64B +13.7% +46.2% 30.0 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $80.46B +1.2% +20.8% 19.4 2.5%
ARGX
Argenx SE
 $61.22B +17.1% — — 2.0%
MRNA
Moderna, Inc.
 $57.48B +388.2% +4.3% — 9.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
19
% held
12.4%
Net QoQ
+104.0K sh
Top holder
Woodline Partners LP
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
54.3K
Days to cover
1.0d
Change
-29.2K sh
View
Short Volume
Short vol %
32%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
440
Value
$664
As of
Aug 13, 2026
View
Off-Exchange
Off-exchange %
60.5%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Insider Trades Cluster buy
Net (90d)
+$136.0K
Buyers / Sellers
6 / 0
Buyers Sellers
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 9, 2026
This year
36
View

Performance

5D 20D 120D MTD YTD
OKYO -9.7% -7.3% -10.8% -7.9% -32.4%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -8.5% -5.5% -28.7% -7.5% -44.5%
Key facts CIK 1849296 CUSIP G6724L116 13F (30d) 10 filings 10 filers Visit website